Jinfa Du
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 34
- Hepatology 18
- Hepatitis C virus research 16
- Co-authors
- Michael J. Sofia (13 shared papers)Michael J. Otto (15 shared papers)Angela M. I. Lam (8 shared papers)Phillip A. Furman (12 shared papers)Suguna Rachakonda (6 shared papers)Chung K. Chu (13 shared papers)Bruce S. Ross (7 shared papers)Shalini Bansal (7 shared papers)
- Journals
- Journal of Medicinal Chemistry (10 papers)Nucleosides Nucleotides & Nucleic Acids (9 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)Bioorganic & Medicinal Chemistry (3 papers)
- Partner nations
- United StatesChinaMexico
In The Last Decade
Jinfa Du
61 papers receiving 1.8k citations
Jinfa Du's Hit Papers
Peers
Comparison fields: 5 of 94
- Hepatology 560
- Infectious Diseases 792
- Virology 109
- Pharmaceutical Science 108
- Toxicology 58
Countries citing papers authored by Jinfa Du
This map shows the geographic impact of Jinfa Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfa Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfa Du more than expected).
Fields of papers citing papers by Jinfa Du
This network shows the impact of papers produced by Jinfa Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfa Du. The network helps show where Jinfa Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinfa Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of a β- d -2′-Deoxy-2′-α-fluoro-2′-β- C -methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus Hit paper breakdown → | 2010 | 544 |
| 2 | 2020 | 131 | |
| 3 | 1996 | 129 | |
| 4 | 2012 | 105 | |
| 5 | 2009 | 76 | |
| 6 | 2000 | 59 | |
| 7 | 2021 | 53 | |
| 8 | 2010 | 53 | |
| 9 | 1999 | 51 | |
| 10 | 2011 | 43 | |
| 11 | 1999 | 41 | |
| 12 | 2005 | 41 | |
| 13 | 2013 | 40 | |
| 14 | 1994 | 39 | |
| 15 | 1994 | 35 | |
| 16 | 2011 | 33 | |
| 17 | 2011 | 32 | |
| 18 | 1997 | 23 | |
| 19 | 2023 | 22 | |
| 20 | 2012 | 22 |
About Jinfa Du
Jinfa Du is a scholar working on Infectious Diseases, Hepatology, Molecular Biology, Epidemiology and Physiology, having authored 64 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (34 papers), Biochemical and Molecular Research (23 papers), Hepatitis C virus research (16 papers), Hepatitis B Virus Studies (10 papers), Plant biochemistry and biosynthesis (8 papers), Adenosine and Purinergic Signaling (5 papers), Plant Gene Expression Analysis (4 papers) and Ginkgo biloba and Cashew Applications (4 papers). The work is most often cited by research in Hepatology (560 citations), Infectious Diseases (792 citations), Virology (109 citations), Pharmaceutical Science (108 citations) and Toxicology (58 citations). Jinfa Du has collaborated with scholars based in United States, China and Mexico. Frequent co-authors include Michael J. Sofia, Michael J. Otto, Angela M. I. Lam, Phillip A. Furman, Suguna Rachakonda, Chung K. Chu, Bruce S. Ross, Shalini Bansal, Holly M. Micolochick Steuer and Christine Espiritu. Their work appears in journals such as Journal of Medicinal Chemistry, Nucleosides Nucleotides & Nucleic Acids, Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.